- Home
- NBN vs HROW Comparison
NBN vs HROW Comparison
Compare NBN & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBN
- HROW
- Stock Information
- Founded
- NBN 1872
- HROW 1998
- Country
- NBN United States
- HROW United States
- Employees
- NBN N/A
- HROW N/A
- Industry
- NBN Major Banks
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- NBN Finance
- HROW Health Care
- Exchange
- NBN Nasdaq
- HROW Nasdaq
- Market Cap
- NBN N/A
- HROW 1.0B
- IPO Year
- NBN N/A
- HROW N/A
- Fundamental
- Price
- NBN $90.89
- HROW $24.98
- Analyst Decision
- NBN Buy
- HROW Strong Buy
- Analyst Count
- NBN 2
- HROW 5
- Target Price
- NBN $97.50
- HROW $58.40
- AVG Volume (30 Days)
- NBN 41.5K
- HROW 691.9K
- Earning Date
- NBN 04-29-2025
- HROW 05-12-2025
- Dividend Yield
- NBN 0.04%
- HROW N/A
- EPS Growth
- NBN 19.89
- HROW N/A
- EPS
- NBN 8.60
- HROW N/A
- Revenue
- NBN $172,133,000.00
- HROW $199,614,000.00
- Revenue This Year
- NBN $35.78
- HROW $45.63
- Revenue Next Year
- NBN $9.58
- HROW $38.04
- P/E Ratio
- NBN $10.65
- HROW N/A
- Revenue Growth
- NBN 20.19
- HROW 53.32
- 52 Week Low
- NBN $50.02
- HROW $9.86
- 52 Week High
- NBN $110.35
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- NBN 39.65
- HROW 41.63
- Support Level
- NBN $92.47
- HROW $25.17
- Resistance Level
- NBN $95.56
- HROW $30.73
- Average True Range (ATR)
- NBN 2.71
- HROW 2.18
- MACD
- NBN 0.13
- HROW 0.20
- Stochastic Oscillator
- NBN 19.79
- HROW 31.23
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.